Catherine Mason Gordon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anorexia Nervosa | 35 | 2024 | 1361 | 6.790 |
Why?
|
| Bone Density | 82 | 2024 | 3549 | 6.750 |
Why?
|
| Vitamin D Deficiency | 40 | 2022 | 1382 | 5.470 |
Why?
|
| Absorptiometry, Photon | 48 | 2023 | 1736 | 4.670 |
Why?
|
| Amenorrhea | 14 | 2024 | 482 | 3.600 |
Why?
|
| Bone and Bones | 28 | 2021 | 2566 | 3.550 |
Why?
|
| Vitamin D | 43 | 2022 | 3296 | 3.180 |
Why?
|
| Primary Ovarian Insufficiency | 4 | 2024 | 107 | 2.790 |
Why?
|
| Dehydroepiandrosterone | 10 | 2019 | 258 | 2.500 |
Why?
|
| Osteoporosis | 23 | 2019 | 1603 | 2.340 |
Why?
|
| Fractures, Bone | 18 | 2022 | 2044 | 2.140 |
Why?
|
| Ergocalciferols | 5 | 2015 | 110 | 2.110 |
Why?
|
| Rickets | 4 | 2022 | 71 | 1.860 |
Why?
|
| Progeria | 6 | 2019 | 188 | 1.700 |
Why?
|
| Adolescent | 149 | 2024 | 88173 | 1.650 |
Why?
|
| Menstrual Cycle | 8 | 2023 | 539 | 1.570 |
Why?
|
| Bone Diseases | 4 | 2017 | 419 | 1.290 |
Why?
|
| Cholecalciferol | 8 | 2022 | 548 | 1.230 |
Why?
|
| Hormone Replacement Therapy | 6 | 2024 | 750 | 1.150 |
Why?
|
| Polycystic Ovary Syndrome | 8 | 2007 | 376 | 1.120 |
Why?
|
| Calcium, Dietary | 6 | 2020 | 529 | 1.110 |
Why?
|
| Gonadotropin-Releasing Hormone | 7 | 2022 | 1147 | 1.100 |
Why?
|
| Norethindrone | 4 | 2018 | 56 | 1.080 |
Why?
|
| Diphosphonates | 8 | 2020 | 636 | 1.060 |
Why?
|
| Puberty | 6 | 2024 | 501 | 1.040 |
Why?
|
| Bone Marrow | 5 | 2022 | 2907 | 1.040 |
Why?
|
| Cystic Fibrosis | 7 | 2021 | 1284 | 1.000 |
Why?
|
| Adrenal Hyperplasia, Congenital | 4 | 2013 | 104 | 0.970 |
Why?
|
| Inflammatory Bowel Diseases | 7 | 2021 | 2419 | 0.940 |
Why?
|
| Levonorgestrel | 4 | 2019 | 74 | 0.940 |
Why?
|
| Lumbar Vertebrae | 7 | 2022 | 1872 | 0.930 |
Why?
|
| Ethinyl Estradiol | 4 | 2019 | 113 | 0.930 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2015 | 84 | 0.890 |
Why?
|
| Child | 86 | 2024 | 80070 | 0.890 |
Why?
|
| Knee | 3 | 2017 | 278 | 0.870 |
Why?
|
| Estrogens | 9 | 2023 | 1519 | 0.870 |
Why?
|
| Spinal Fractures | 7 | 2022 | 705 | 0.860 |
Why?
|
| Vitamins | 8 | 2017 | 1632 | 0.860 |
Why?
|
| Adolescent Health Services | 3 | 2022 | 218 | 0.860 |
Why?
|
| Hypogonadism | 3 | 2023 | 798 | 0.860 |
Why?
|
| Hypothalamic Diseases | 2 | 2017 | 134 | 0.850 |
Why?
|
| Female | 165 | 2024 | 391766 | 0.840 |
Why?
|
| Crohn Disease | 6 | 2022 | 2277 | 0.840 |
Why?
|
| Adolescent Development | 3 | 2020 | 282 | 0.830 |
Why?
|
| Pregnancy in Adolescence | 2 | 2022 | 163 | 0.830 |
Why?
|
| Parathyroid Hormone | 17 | 2019 | 1802 | 0.820 |
Why?
|
| Bone Development | 3 | 2020 | 472 | 0.800 |
Why?
|
| Medroxyprogesterone | 1 | 2021 | 35 | 0.790 |
Why?
|
| Humans | 219 | 2024 | 760239 | 0.780 |
Why?
|
| Estrogens, Conjugated (USP) | 4 | 2018 | 276 | 0.750 |
Why?
|
| Anthropometry | 9 | 2017 | 1349 | 0.750 |
Why?
|
| Exercise | 10 | 2017 | 5807 | 0.670 |
Why?
|
| Sex Reassignment Surgery | 1 | 2022 | 164 | 0.670 |
Why?
|
| Dietary Supplements | 16 | 2022 | 3396 | 0.670 |
Why?
|
| Pregnancy Rate | 1 | 2022 | 648 | 0.670 |
Why?
|
| Body Composition | 13 | 2023 | 2421 | 0.660 |
Why?
|
| Bone Density Conservation Agents | 6 | 2020 | 795 | 0.640 |
Why?
|
| Calcification, Physiologic | 2 | 2017 | 170 | 0.640 |
Why?
|
| Endometriosis | 5 | 2018 | 869 | 0.620 |
Why?
|
| Adipose Tissue | 7 | 2022 | 3305 | 0.610 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2018 | 83 | 0.610 |
Why?
|
| Femur Neck | 3 | 2015 | 314 | 0.600 |
Why?
|
| Bone Remodeling | 5 | 2011 | 581 | 0.590 |
Why?
|
| Coronavirus | 1 | 2020 | 153 | 0.590 |
Why?
|
| Pediatrics | 6 | 2021 | 3593 | 0.570 |
Why?
|
| Turner Syndrome | 1 | 2018 | 130 | 0.560 |
Why?
|
| Fractures, Spontaneous | 2 | 2017 | 231 | 0.530 |
Why?
|
| Double-Blind Method | 18 | 2024 | 12314 | 0.520 |
Why?
|
| Sexual Maturation | 1 | 2017 | 261 | 0.520 |
Why?
|
| Young Adult | 46 | 2024 | 59054 | 0.520 |
Why?
|
| Bone Resorption | 5 | 2015 | 723 | 0.520 |
Why?
|
| Contraceptives, Oral, Combined | 2 | 2014 | 116 | 0.520 |
Why?
|
| Leuprolide | 3 | 2018 | 311 | 0.510 |
Why?
|
| Ovarian Diseases | 2 | 2020 | 137 | 0.490 |
Why?
|
| Forearm | 2 | 2019 | 427 | 0.490 |
Why?
|
| Family Planning Services | 2 | 2022 | 267 | 0.490 |
Why?
|
| Quality of Life | 6 | 2022 | 13336 | 0.470 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 579 | 0.470 |
Why?
|
| Menarche | 6 | 2020 | 531 | 0.460 |
Why?
|
| Densitometry | 1 | 2014 | 151 | 0.460 |
Why?
|
| Tibia | 4 | 2019 | 1069 | 0.450 |
Why?
|
| Dehydroepiandrosterone Sulfate | 3 | 2006 | 241 | 0.450 |
Why?
|
| Adiposity | 2 | 2022 | 1867 | 0.440 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2011 | 155 | 0.430 |
Why?
|
| Contraception | 2 | 2018 | 348 | 0.430 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2010 | 698 | 0.430 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2013 | 53 | 0.420 |
Why?
|
| Fluorocarbons | 3 | 2024 | 491 | 0.420 |
Why?
|
| Adolescent Behavior | 3 | 2018 | 1186 | 0.410 |
Why?
|
| Estrogen Replacement Therapy | 5 | 2015 | 1207 | 0.410 |
Why?
|
| Menstruation | 1 | 2014 | 307 | 0.400 |
Why?
|
| Alkaline Phosphatase | 4 | 2009 | 866 | 0.400 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2020 | 1928 | 0.390 |
Why?
|
| Contraception, Postcoital | 1 | 2011 | 20 | 0.390 |
Why?
|
| Formularies as Topic | 1 | 2012 | 93 | 0.390 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 3 | 2015 | 62 | 0.380 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 374 | 0.380 |
Why?
|
| S100 Proteins | 1 | 2012 | 218 | 0.380 |
Why?
|
| Calcium | 11 | 2019 | 5726 | 0.370 |
Why?
|
| Male | 83 | 2024 | 359943 | 0.370 |
Why?
|
| Progestins | 2 | 2012 | 301 | 0.370 |
Why?
|
| Fractures, Stress | 3 | 2011 | 201 | 0.370 |
Why?
|
| Nutritional Status | 7 | 2011 | 1612 | 0.370 |
Why?
|
| Thinness | 1 | 2014 | 490 | 0.370 |
Why?
|
| Malnutrition | 3 | 2014 | 644 | 0.370 |
Why?
|
| Hip | 5 | 2014 | 254 | 0.360 |
Why?
|
| Leptin | 4 | 2017 | 1593 | 0.360 |
Why?
|
| Contraceptive Agents, Female | 1 | 2011 | 118 | 0.360 |
Why?
|
| Calcinosis | 1 | 2019 | 1469 | 0.350 |
Why?
|
| Femur | 3 | 2019 | 1308 | 0.350 |
Why?
|
| Administration, Oral | 6 | 2018 | 4010 | 0.350 |
Why?
|
| Human Growth Hormone | 2 | 2012 | 638 | 0.350 |
Why?
|
| Glucocorticoids | 5 | 2008 | 2160 | 0.350 |
Why?
|
| Child, Preschool | 23 | 2019 | 42204 | 0.340 |
Why?
|
| Calcitonin | 1 | 2011 | 329 | 0.340 |
Why?
|
| Weight Loss | 3 | 2011 | 2682 | 0.340 |
Why?
|
| Calcifediol | 4 | 2017 | 161 | 0.330 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2012 | 348 | 0.330 |
Why?
|
| Environmental Pollutants | 4 | 2024 | 1274 | 0.330 |
Why?
|
| Bone Diseases, Metabolic | 4 | 2021 | 409 | 0.330 |
Why?
|
| Pseudomonas Infections | 1 | 2014 | 622 | 0.330 |
Why?
|
| Infertility, Female | 1 | 2015 | 758 | 0.330 |
Why?
|
| Urban Population | 3 | 2017 | 2030 | 0.320 |
Why?
|
| Infant | 20 | 2019 | 36179 | 0.320 |
Why?
|
| Adult | 58 | 2022 | 220718 | 0.320 |
Why?
|
| Bed Rest | 1 | 2009 | 83 | 0.320 |
Why?
|
| Cranial Irradiation | 1 | 2011 | 390 | 0.320 |
Why?
|
| Health | 2 | 2011 | 397 | 0.320 |
Why?
|
| Body Mass Index | 10 | 2022 | 12917 | 0.310 |
Why?
|
| Radius | 2 | 2014 | 440 | 0.310 |
Why?
|
| Obesity | 7 | 2022 | 12908 | 0.310 |
Why?
|
| Ovary | 3 | 2010 | 958 | 0.310 |
Why?
|
| Infant Welfare | 1 | 2008 | 80 | 0.300 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2008 | 144 | 0.290 |
Why?
|
| Boston | 12 | 2019 | 9324 | 0.290 |
Why?
|
| Weight Gain | 4 | 2012 | 2346 | 0.290 |
Why?
|
| Spine | 5 | 2018 | 1118 | 0.280 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3760 | 0.280 |
Why?
|
| Colitis, Ulcerative | 3 | 2014 | 1921 | 0.280 |
Why?
|
| Cross-Sectional Studies | 23 | 2022 | 26043 | 0.270 |
Why?
|
| Anti-HIV Agents | 6 | 2018 | 4518 | 0.270 |
Why?
|
| Societies, Medical | 6 | 2020 | 3903 | 0.270 |
Why?
|
| Prevalence | 12 | 2018 | 15689 | 0.270 |
Why?
|
| Reproductive Medicine | 2 | 2018 | 99 | 0.270 |
Why?
|
| Case-Control Studies | 9 | 2022 | 22079 | 0.270 |
Why?
|
| Women's Health | 2 | 2023 | 2054 | 0.260 |
Why?
|
| Gender Identity | 2 | 2022 | 765 | 0.260 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 1008 | 0.260 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 1278 | 0.260 |
Why?
|
| Cross-Cultural Comparison | 1 | 2009 | 635 | 0.260 |
Why?
|
| Pravastatin | 2 | 2019 | 392 | 0.260 |
Why?
|
| Social Justice | 2 | 2020 | 478 | 0.260 |
Why?
|
| Menstruation Disturbances | 3 | 2008 | 143 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2020 | 36351 | 0.250 |
Why?
|
| Risk Factors | 23 | 2020 | 73999 | 0.250 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 606 | 0.250 |
Why?
|
| Child Development | 2 | 2014 | 2302 | 0.240 |
Why?
|
| Pilot Projects | 6 | 2023 | 8610 | 0.240 |
Why?
|
| Musculoskeletal System | 1 | 2007 | 188 | 0.240 |
Why?
|
| Antidepressive Agents | 1 | 2016 | 2897 | 0.230 |
Why?
|
| Biomedical Research | 3 | 2011 | 3421 | 0.230 |
Why?
|
| Periodontal Diseases | 1 | 2008 | 451 | 0.230 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 15454 | 0.230 |
Why?
|
| Child Welfare | 1 | 2008 | 519 | 0.230 |
Why?
|
| Estradiol | 5 | 2023 | 1934 | 0.230 |
Why?
|
| Statistics, Nonparametric | 4 | 2011 | 2850 | 0.230 |
Why?
|
| Ultrasonography | 6 | 2007 | 5966 | 0.220 |
Why?
|
| Piperidines | 3 | 2019 | 1656 | 0.220 |
Why?
|
| Caprylates | 2 | 2024 | 114 | 0.220 |
Why?
|
| Mandible | 1 | 2008 | 753 | 0.210 |
Why?
|
| Sex Characteristics | 2 | 2013 | 2632 | 0.210 |
Why?
|
| Contraceptives, Oral, Hormonal | 3 | 2012 | 190 | 0.210 |
Why?
|
| Radiography | 6 | 2012 | 6963 | 0.210 |
Why?
|
| Drug Administration Schedule | 5 | 2015 | 4848 | 0.210 |
Why?
|
| Drug Therapy, Combination | 5 | 2016 | 6297 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3081 | 0.200 |
Why?
|
| Oral Health | 1 | 2008 | 487 | 0.200 |
Why?
|
| Osteogenesis | 3 | 2006 | 1273 | 0.200 |
Why?
|
| Reference Values | 5 | 2014 | 4921 | 0.200 |
Why?
|
| Sports | 3 | 2007 | 701 | 0.200 |
Why?
|
| Physicians | 1 | 2020 | 4584 | 0.190 |
Why?
|
| Osteoporotic Fractures | 3 | 2017 | 411 | 0.190 |
Why?
|
| Infant, Newborn | 10 | 2022 | 26282 | 0.190 |
Why?
|
| Nutritional Requirements | 3 | 2012 | 275 | 0.190 |
Why?
|
| Child Nutrition Disorders | 1 | 2003 | 150 | 0.190 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2023 | 725 | 0.190 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2011 | 362 | 0.190 |
Why?
|
| Hypothyroidism | 2 | 1997 | 667 | 0.190 |
Why?
|
| Dihydrotestosterone | 1 | 2001 | 195 | 0.190 |
Why?
|
| Sexual Behavior | 2 | 2003 | 2177 | 0.190 |
Why?
|
| Phthalic Acids | 2 | 2023 | 478 | 0.190 |
Why?
|
| Galactosemias | 2 | 2012 | 124 | 0.180 |
Why?
|
| Prospective Studies | 18 | 2019 | 54304 | 0.180 |
Why?
|
| Age Factors | 10 | 2017 | 18369 | 0.180 |
Why?
|
| Hospitals, Urban | 1 | 2022 | 500 | 0.180 |
Why?
|
| Aminophenols | 1 | 2021 | 87 | 0.180 |
Why?
|
| Regression Analysis | 4 | 2018 | 6336 | 0.170 |
Why?
|
| Pituitary-Adrenal System | 2 | 2000 | 549 | 0.170 |
Why?
|
| Pyridines | 3 | 2019 | 2868 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2015 | 10758 | 0.170 |
Why?
|
| Decanoic Acids | 1 | 2019 | 68 | 0.170 |
Why?
|
| Diet Therapy | 1 | 2020 | 150 | 0.170 |
Why?
|
| Singapore | 1 | 2020 | 287 | 0.160 |
Why?
|
| Osteocalcin | 3 | 2009 | 274 | 0.160 |
Why?
|
| Androgens | 3 | 2007 | 1282 | 0.160 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 12050 | 0.160 |
Why?
|
| Life Style | 6 | 2024 | 3902 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2018 | 5663 | 0.160 |
Why?
|
| Retrospective Studies | 12 | 2022 | 80414 | 0.160 |
Why?
|
| Treatment Outcome | 14 | 2018 | 64583 | 0.160 |
Why?
|
| Food | 2 | 2020 | 771 | 0.160 |
Why?
|
| Motor Activity | 2 | 2011 | 2687 | 0.150 |
Why?
|
| Body Height | 4 | 2020 | 1570 | 0.150 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 1998 | 10 | 0.150 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 277 | 0.150 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2022 | 295 | 0.150 |
Why?
|
| Cohort Studies | 13 | 2021 | 41340 | 0.150 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2020 | 407 | 0.150 |
Why?
|
| Lamin Type A | 1 | 2019 | 187 | 0.150 |
Why?
|
| Fertility | 1 | 2003 | 771 | 0.150 |
Why?
|
| Resistance Training | 1 | 2020 | 191 | 0.150 |
Why?
|
| HIV Infections | 8 | 2018 | 17328 | 0.150 |
Why?
|
| Adenine | 2 | 2014 | 986 | 0.150 |
Why?
|
| Diagnostic Errors | 2 | 2016 | 1264 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 2242 | 0.150 |
Why?
|
| Rhode Island | 1 | 2018 | 350 | 0.150 |
Why?
|
| Mental Health | 2 | 2023 | 3239 | 0.150 |
Why?
|
| Overweight | 2 | 2022 | 2409 | 0.150 |
Why?
|
| Quinolones | 1 | 2021 | 378 | 0.150 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.140 |
Why?
|
| Skin Pigmentation | 2 | 2017 | 277 | 0.140 |
Why?
|
| Endocrine System Diseases | 3 | 2011 | 249 | 0.140 |
Why?
|
| Triglycerides | 3 | 2022 | 2455 | 0.140 |
Why?
|
| Motivation | 2 | 2005 | 2006 | 0.140 |
Why?
|
| Energy Intake | 4 | 2016 | 2133 | 0.140 |
Why?
|
| Body Weight | 4 | 2014 | 4609 | 0.140 |
Why?
|
| Histamine H2 Antagonists | 1 | 2018 | 166 | 0.140 |
Why?
|
| Tomography, Emission-Computed | 1 | 2000 | 1122 | 0.140 |
Why?
|
| Alkanesulfonic Acids | 1 | 2019 | 200 | 0.140 |
Why?
|
| Ohio | 1 | 2017 | 322 | 0.140 |
Why?
|
| Seasons | 4 | 2017 | 1518 | 0.140 |
Why?
|
| Contraception Behavior | 1 | 2018 | 181 | 0.140 |
Why?
|
| Exercise Therapy | 2 | 2014 | 925 | 0.130 |
Why?
|
| Weight-Bearing | 2 | 2011 | 531 | 0.130 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2016 | 78 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2007 | 3187 | 0.130 |
Why?
|
| Creatinine | 2 | 2019 | 1898 | 0.130 |
Why?
|
| Parenteral Nutrition | 2 | 2011 | 659 | 0.130 |
Why?
|
| Growth | 1 | 2017 | 365 | 0.130 |
Why?
|
| Water | 1 | 2022 | 1408 | 0.130 |
Why?
|
| Neoplasms | 3 | 2023 | 22077 | 0.130 |
Why?
|
| Povidone-Iodine | 1 | 1995 | 55 | 0.130 |
Why?
|
| Calcitriol | 2 | 2015 | 297 | 0.130 |
Why?
|
| Skin Care | 1 | 1995 | 57 | 0.130 |
Why?
|
| Waist Circumference | 1 | 2019 | 927 | 0.130 |
Why?
|
| Puberty, Precocious | 1 | 1997 | 164 | 0.130 |
Why?
|
| Uterine Hemorrhage | 1 | 1997 | 240 | 0.120 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 152 | 0.120 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 39067 | 0.120 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 5491 | 0.120 |
Why?
|
| Anemia, Sickle Cell | 2 | 2014 | 1063 | 0.120 |
Why?
|
| Maternal-Child Health Centers | 1 | 2015 | 42 | 0.120 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 27 | 0.120 |
Why?
|
| Chronic Disease | 4 | 2014 | 9304 | 0.120 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2015 | 116 | 0.120 |
Why?
|
| Patient Compliance | 3 | 2012 | 2686 | 0.120 |
Why?
|
| Parietal Lobe | 1 | 2000 | 850 | 0.120 |
Why?
|
| Age Determination by Skeleton | 2 | 2014 | 126 | 0.120 |
Why?
|
| Accidental Falls | 2 | 2020 | 1066 | 0.120 |
Why?
|
| Hyperparathyroidism | 2 | 2015 | 337 | 0.120 |
Why?
|
| 25-Hydroxyvitamin D 2 | 2 | 2012 | 40 | 0.120 |
Why?
|
| Severity of Illness Index | 8 | 2017 | 15818 | 0.120 |
Why?
|